Ambri gets new business software

By Daniella Goldberg
Wednesday, 01 May, 2002

Ambri has adopted new business software and services from Frontstep, to help it to take its new clinical diagnostic system from prototype to full-scale manufacture.

Ambri's CEO and managing director, Joe Shaw, said Frontstep's solution will provide a flexible and highly scalable platform for the company as it moves closer toward establishing commercial manufacturing operations and its North American expansion.

Frontsteps' SyteLine provides a business management platform that will allow Ambri to satisfy the US Food and Drug Administration regulations.

"We will not become a global organisation without people and suppliers who are dedicated to joining with us to achieve this objective," said Shaw.

Related News

New molecular mechanism found for depression

Depression may not only result from simple neuronal damage but can also arise from the...

Over-the-counter medications linked to antibiotic resistance

Over-the-counter medications such as ibuprofen and paracetamol are quietly driving antibiotic...

Subtle heart dysfunction detected in young adults with bipolar

A new study reveals that myocardial dysfunction is already evident in patients with bipolar...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd